• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将普萘洛尔-硅酸镁铝插层复合物用作聚合物基质片剂中的药物储库。

Use of propranolol-magnesium aluminium silicate intercalated complexes as drug reservoirs in polymeric matrix tablets.

作者信息

Pongjanyakul T, Rojtanatanya S

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen-40002, Thailand.

出版信息

Indian J Pharm Sci. 2012 Jul;74(4):292-301. doi: 10.4103/0250-474X.107048.

DOI:10.4103/0250-474X.107048
PMID:23626384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3630724/
Abstract

The objective of the present study was to investigate the use of propranolol-magnesium aluminium silicate intercalated complexes as drug reservoirs in hydroxypropylmethylcellulose tablets. The matrix tablets containing the complexes were prepared and characterised with respect to propranolol release and were subsequently compared with those loading propranolol or a propranolol-magnesium aluminium silicate physical mixture. Additionally, the effects of varying viscosity grades of hydroxypropyl methylcellulose, compression pressures and calcium acetate incorporation on the drug release characteristics of the complex-loaded tablets were also examined. The results showed that the complex-loaded tablets have higher tablet hardness than those containing propranolol or a physical mixture. The drug release from the complex-loaded tablets followed a zero-order release kinetic, whereas an anomalous transport was found in the propranolol or physical mixture tablets. The drug release rate of the complex tablet significantly decreased with increasing hydroxypropylmethylcellulose viscosity grade. Increase in the compression pressure caused a decrease in the drug release rate of the tablets. Furthermore, the incorporation of calcium ions could accelerate propranolol release, particularly in acidic medium, because calcium ions could be exchanged with propranolol molecules intercalated in the silicate layers of magnesium aluminium silicate. These findings suggest that propranolol-magnesium aluminium silicate intercalated complexes show strong potential for use as drug reservoirs in matrix tablets intended for modifying drug release.

摘要

本研究的目的是考察普萘洛尔 - 硅酸镁铝插层复合物作为羟丙基甲基纤维素片剂中药物储库的应用。制备了含有该复合物的基质片剂,并对其普萘洛尔释放情况进行了表征,随后与装载普萘洛尔或普萘洛尔 - 硅酸镁铝物理混合物的片剂进行了比较。此外,还研究了不同粘度等级的羟丙基甲基纤维素、压片压力以及醋酸钙的加入对载有复合物片剂药物释放特性的影响。结果表明,载有复合物的片剂比含有普萘洛尔或物理混合物的片剂具有更高的片剂硬度。载有复合物片剂的药物释放遵循零级释放动力学,而在普萘洛尔或物理混合物片剂中发现了非正规转运。随着羟丙基甲基纤维素粘度等级的增加,复合物片剂的药物释放速率显著降低。压片压力的增加导致片剂的药物释放速率降低。此外,钙离子的加入可以加速普萘洛尔的释放,特别是在酸性介质中,因为钙离子可以与插层在硅酸镁铝硅酸盐层中的普萘洛尔分子进行交换。这些发现表明,普萘洛尔 - 硅酸镁铝插层复合物在用作旨在调节药物释放的基质片剂中的药物储库方面具有很大的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/de6dbffe62a0/IJPhS-74-292-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/2d4adb7fd718/IJPhS-74-292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/62835dcb5630/IJPhS-74-292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/21089edf1c37/IJPhS-74-292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/ef0547819e03/IJPhS-74-292-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/2ca9419e19c2/IJPhS-74-292-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/de6dbffe62a0/IJPhS-74-292-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/2d4adb7fd718/IJPhS-74-292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/62835dcb5630/IJPhS-74-292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/21089edf1c37/IJPhS-74-292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/ef0547819e03/IJPhS-74-292-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/2ca9419e19c2/IJPhS-74-292-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/3630724/de6dbffe62a0/IJPhS-74-292-g011.jpg

相似文献

1
Use of propranolol-magnesium aluminium silicate intercalated complexes as drug reservoirs in polymeric matrix tablets.将普萘洛尔-硅酸镁铝插层复合物用作聚合物基质片剂中的药物储库。
Indian J Pharm Sci. 2012 Jul;74(4):292-301. doi: 10.4103/0250-474X.107048.
2
Influence of pH modifiers and HPMC viscosity grades on nicotine-magnesium aluminum silicate complex-loaded buccal matrix tablets.pH 调节剂和 HPMC 黏度级别的影响对尼古丁-镁铝硅酸盐复合物负载的颊腔基质片。
AAPS PharmSciTech. 2012 Jun;13(2):674-85. doi: 10.1208/s12249-012-9790-7. Epub 2012 May 3.
3
Propranolol-magnesium aluminum silicate complex dispersions and particles: characterization and factors influencing drug release.普萘洛尔-硅酸镁铝复合物分散体和颗粒:特性及影响药物释放的因素。
Int J Pharm. 2010 Jan 4;383(1-2):106-15. doi: 10.1016/j.ijpharm.2009.09.016. Epub 2009 Sep 12.
4
Novel chitosan-magnesium aluminum silicate nanocomposite film coatings for modified-release tablets.新型壳聚糖-镁铝硅纳米复合膜涂层用于控释片剂。
Int J Pharm. 2011 Apr 4;407(1-2):132-41. doi: 10.1016/j.ijpharm.2011.01.049. Epub 2011 Feb 1.
5
A molecular understanding of magnesium aluminium silicate - drug, drug - polymer, magnesium aluminium silicate - polymer nanocomposite complex interactions in modulating drug release: Towards zero order release.镁铝硅酸盐-药物、药物-聚合物、镁铝硅酸盐-聚合物纳米复合物相互作用的分子基础:调控药物释放-向零级释放迈进。
Eur J Pharm Biopharm. 2020 Sep;154:270-282. doi: 10.1016/j.ejpb.2020.07.027. Epub 2020 Jul 25.
6
Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.使用含药聚合物包衣对双药负载羟丙基甲基纤维素基质片剂进行控释。
Int J Pharm. 1999 Oct 15;188(1):71-80. doi: 10.1016/s0378-5173(99)00204-5.
7
Preparation and characterization of nicotine-magnesium aluminum silicate complex-loaded sodium alginate matrix tablets for buccal delivery.制备并表征载有尼古丁-硅酸镁铝复合物的海藻酸钠基质片剂用于口腔给药。
AAPS PharmSciTech. 2011 Jun;12(2):683-92. doi: 10.1208/s12249-011-9633-y. Epub 2011 May 19.
8
Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and hydroxypropylmethylcellulose.盐酸普萘洛尔从含有羧甲基纤维素钠和羟丙基甲基纤维素的骨架片中的释放。
Pharm Dev Technol. 1999 Aug;4(3):313-24. doi: 10.1081/pdt-100101367.
9
Sodium caseinate-magnesium aluminum silicate nanocomposite films for modified-release tablets.用于控释片剂的酪蛋白酸钠-镁铝硅酸盐纳米复合材料薄膜。
Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:827-839. doi: 10.1016/j.msec.2018.07.040. Epub 2018 Jul 19.
10
Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.亲水型羟丙甲纤维素基质片的药物释放调节机制:原子和载体的分布及织构分析。
Curr Drug Deliv. 2013 Dec;10(6):732-41. doi: 10.2174/156720181006131125155652.

引用本文的文献

1
Exploration of Neusilin US2 as an Acceptable Filler in HPMC Matrix Systems-Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study.探索纽西兰US2作为羟丙基甲基纤维素(HPMC)基质系统中可接受填充剂的研究——药典法与动态生物相关溶出度研究的比较
Pharmaceutics. 2022 Jan 5;14(1):127. doi: 10.3390/pharmaceutics14010127.
2
Thermodynamics of clay-drug complex dispersions: Isothermal titration calorimetry and high-performance liquid chromatography.黏土-药物复合物分散体的热力学:等温滴定量热法和高效液相色谱法
J Pharm Anal. 2020 Feb;10(1):78-85. doi: 10.1016/j.jpha.2019.12.001. Epub 2019 Dec 5.
3
Real time calorimetric characterisation of clay - drug complex dispersions and particles.

本文引用的文献

1
Mathematical modeling of drug release from lipid dosage forms.从脂质剂型中释放药物的数学模型。
Int J Pharm. 2011 Oct 10;418(1):42-53. doi: 10.1016/j.ijpharm.2011.07.015. Epub 2011 Jul 23.
2
Preparation and characterization of nicotine-magnesium aluminum silicate complex-loaded sodium alginate matrix tablets for buccal delivery.制备并表征载有尼古丁-硅酸镁铝复合物的海藻酸钠基质片剂用于口腔给药。
AAPS PharmSciTech. 2011 Jun;12(2):683-92. doi: 10.1208/s12249-011-9633-y. Epub 2011 May 19.
3
Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
粘土-药物复合物分散体和颗粒的实时量热表征
Int J Pharm X. 2018 Dec 21;1:100003. doi: 10.1016/j.ijpx.2018.100003. eCollection 2019 Dec.
瓜尔胶、黄原胶和 HPMC 可以控制盐酸普萘洛尔的释放机制和缓释。
AAPS PharmSciTech. 2011 Mar;12(1):77-87. doi: 10.1208/s12249-010-9570-1. Epub 2010 Dec 21.
4
Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.药物溶解度对 HPMC 基质制剂中水溶性和难溶性药物释放动力学的影响。
Acta Pharm. 2009 Sep;59(3):313-23. doi: 10.2478/v10007-009-0025-8.
5
Propranolol-magnesium aluminum silicate complex dispersions and particles: characterization and factors influencing drug release.普萘洛尔-硅酸镁铝复合物分散体和颗粒:特性及影响药物释放的因素。
Int J Pharm. 2010 Jan 4;383(1-2):106-15. doi: 10.1016/j.ijpharm.2009.09.016. Epub 2009 Sep 12.
6
Pellet characteristics and drug release when the form of propranolol is fixed as moles or mass in formulations for extruded and spheronized Carbopol-containing pellets.
Int J Pharm. 2009 Mar 18;369(1-2):96-104. doi: 10.1016/j.ijpharm.2008.11.002. Epub 2008 Nov 11.
7
Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.含聚乙烯吡咯烷酮SR或羟丙基甲基纤维素的基质片对盐酸普萘洛尔释放的对比研究。
AAPS PharmSciTech. 2008;9(2):577-82. doi: 10.1208/s12249-008-9092-2. Epub 2008 May 6.
8
Loading and delivery of sertraline using inorganic micro and mesoporous materials.
Eur J Pharm Biopharm. 2007 Jun;66(3):357-65. doi: 10.1016/j.ejpb.2006.11.023. Epub 2006 Dec 5.
9
Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.新型盐酸普萘洛尔缓释右旋糖酐片剂制剂的研发与优化
Int J Pharm. 2006 Jul 6;317(1):32-9. doi: 10.1016/j.ijpharm.2006.02.049. Epub 2006 Apr 11.
10
Melted glyceryl palmitostearate (GPS) pellets for protein delivery.用于蛋白质递送的熔融甘油棕榈硬脂酸酯(GPS)微丸。
Int J Pharm. 2004 Mar 1;271(1-2):53-62. doi: 10.1016/j.ijpharm.2003.10.017.